Symbol="ALPN"
AssetType="Common Stock"
Name="Alpine Immune Sciences Inc"
Description="Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune / inflammatory disorders, and other diseases. The company is headquartered in Seattle, Washington."
CIK="1626199"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="201 ELLIOTT AVE. WEST, SUITE 230, SEATTLE, WA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="659530000"
EBITDA="-65693000"
PERatio="None"
PEGRatio="0"
BookValue="3.55"
DividendPerShare="0"
DividendYield="0"
EPS="-1.72"
RevenuePerShareTTM="0.684"
ProfitMargin="-2.459"
OperatingMarginTTM="-2.567"
ReturnOnAssetsTTM="-0.167"
ReturnOnEquityTTM="-0.446"
RevenueTTM="25822000"
GrossProfitTTM="-40179000"
DilutedEPSTTM="-1.72"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.311"
AnalystTargetPrice="15"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="9.42"
PriceToBookRatio="1.524"
EVToRevenue="1.385"
EVToEBITDA="-0.857"
Beta="1.233"
num_52WeekHigh="13.79"
num_52WeekLow="4.82"
num_50DayMovingAverage="10.98"
num_200DayMovingAverage="8.2"
SharesOutstanding="47965800"
DividendDate="2017-07-25"
ExDividendDate="None"
symbol="ALPN"
open="13.20"
high="13.79"
low="12.97"
price="13.75"
volume="182779.00"
latest_trading_day="2023-08-02"
previous_close="13.27"
change="0.48"
change_percent="3.6172%"
aroon_positive_momentum_days="68"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Trending Low"
value_analysis="Bearish Trend"
Aroon_change="FALSE"
Aroon_momentum="68"
Volume_recent_avg="161553"
Change_recent_avg="0.06"
Delta_recent_avg="0.54"
Variance_recent_avg="0.27"
Change_ratio_recent_avg="0.51"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="68"
Aroon_momentum_negative="32"
image_negative_thumbnail_id_1="1163"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0197.jpeg"
image_negative_thumbnail_id_2="102"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0074.jpeg"
image_neutral_thumbnail_id_1="530"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0069.jpeg"
image_neutral_thumbnail_id_2="588"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0011.jpeg"
image_positive_thumbnail_id_1="623"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0085.jpeg"
image_positive_thumbnail_id_2="981"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0143.jpeg"
image_professor_thumbnail_id_1="1199"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0033.jpeg"
image_professor_thumbnail_id_2="1176"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0010.jpeg"
